Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava

[1]  K. Park,et al.  Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. , 2012, Biological & pharmaceutical bulletin.

[2]  K. Park,et al.  Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases , 2012, Bioorganic & Medicinal Chemistry.

[3]  Su-Jin Park,et al.  Influenza virus neuraminidase inhibitory activity of phlorotannins from the edible brown alga Ecklonia cava. , 2011, Journal of agricultural and food chemistry.

[4]  Kil-Nam Kim,et al.  Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. , 2010, European journal of pharmacology.

[5]  K. Park,et al.  Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition , 2010, Bioorganic & Medicinal Chemistry.

[6]  K. Park,et al.  SARS‐CoV 3CLpro Inhibitory Effects of Quinone‐Methide Triterpenes from Tripterygium regelii. , 2010 .

[7]  Jang-Gi Choi,et al.  Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp. , 2010, Foodborne pathogens and disease.

[8]  Ji-Sook Han,et al.  Protective effects of enzymatic digest from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells. , 2010, Journal of the science of food and agriculture.

[9]  Won‐Kyo Jung,et al.  Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. , 2009, Journal of agricultural and food chemistry.

[10]  N. Yoon,et al.  Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells. , 2009, Journal of agricultural and food chemistry.

[11]  M. Hsu,et al.  Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds , 2009, Journal of Biological Chemistry.

[12]  F. Karadeniz,et al.  Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava. , 2008, Bioorganic & medicinal chemistry.

[13]  R. Bauer,et al.  Anti-inflammatory phloroglucinol derivatives from Hypericum empetrifolium. , 2008, Phytochemistry letters.

[14]  N. Lee,et al.  Antioxidant activities of phlorotannins purified from Ecklonia cava on free radical scavenging using ESR and H2O2-mediated DNA damage , 2007 .

[15]  Po-Huang Liang,et al.  Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. , 2007, Journal of medicinal chemistry.

[16]  Won‐Kyo Jung,et al.  Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. , 2006, Life sciences.

[17]  F. Tsai,et al.  Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds , 2005, Antiviral Research.

[18]  Chi‐Huey Wong,et al.  Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. , 2005, Journal of medicinal chemistry.

[19]  Jindrich Cinatl,et al.  Development of antiviral therapy for severe acute respiratory syndrome , 2005, Antiviral Research.

[20]  Herman Tse,et al.  Identification of Novel Small-Molecule Inhibitors of Severe Acute Respiratory Syndrome-Associated Coronavirus by Chemical Genetics , 2004, Chemistry & Biology.

[21]  Pei-Jer Chen,et al.  Characterization of trans‐ and cis‐cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti‐SARS drugs , 2004, FEBS Letters.

[22]  Marie M. Ahlström,et al.  Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[23]  J. Ziebuhr,et al.  Molecular biology of severe acute respiratory syndrome coronavirus , 2004, Current Opinion in Microbiology.

[24]  Hsuan-Cheng Huang,et al.  Small molecules targeting severe acute respiratory syndrome human coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Rappuoli,et al.  SARS — beginning to understand a new virus , 2003, Nature Reviews Microbiology.

[26]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Kaixian Chen,et al.  Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus , 2003, Protein Expression and Purification.

[28]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[29]  D. Rasschaert,et al.  Identification of a new cleavage site of the 3C-like protease of rabbit haemorrhagic disease virus. , 2000, The Journal of general virology.

[30]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[31]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[32]  C. F. Chang,et al.  Chinese seaweeds in herbal medicine , 1984, Hydrobiologia.

[33]  Ralph Weissleder,et al.  Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. , 2010, Bioconjugate chemistry.